↓ Skip to main content

Cochrane Database of Systematic Reviews

Cholinesterase inhibitors for rarer dementias associated with neurological conditions

Overview of attention for article published in Cochrane database of systematic reviews, March 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
250 Mendeley
Title
Cholinesterase inhibitors for rarer dementias associated with neurological conditions
Published in
Cochrane database of systematic reviews, March 2015
DOI 10.1002/14651858.cd009444.pub3
Pubmed ID
Authors

Ying Li, Shan Hai, Yan Zhou, Bi Rong Dong

Abstract

Rarer dementias include Huntington's disease (HD), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), frontotemporal dementia (FTD), dementia in multiple sclerosis (MS) and progressive supranuclear palsy (PSP). Cholinesterase inhibitors, including donepezil, galantamine and rivastigmine, are considered to be the first-line medicines for Alzheimer's disease and some other dementias, such as dementia in Parkinson's disease. Cholinesterase inhibitors are hypothesised to work by inhibiting the enzyme acetylcholinesterase (AChE) which breaks down the neurotransmitter acetylcholine. Cholinesterase inhibitors may also lead to clinical improvement for rarer dementias associated with neurological conditions.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 250 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Czechia 1 <1%
Germany 1 <1%
Unknown 246 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 39 16%
Student > Master 37 15%
Student > Ph. D. Student 34 14%
Researcher 32 13%
Student > Postgraduate 19 8%
Other 42 17%
Unknown 47 19%
Readers by discipline Count As %
Medicine and Dentistry 80 32%
Psychology 30 12%
Nursing and Health Professions 23 9%
Neuroscience 18 7%
Biochemistry, Genetics and Molecular Biology 9 4%
Other 32 13%
Unknown 58 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2020.
All research outputs
#4,995,299
of 17,033,237 outputs
Outputs from Cochrane database of systematic reviews
#7,529
of 11,616 outputs
Outputs of similar age
#64,101
of 221,417 outputs
Outputs of similar age from Cochrane database of systematic reviews
#171
of 253 outputs
Altmetric has tracked 17,033,237 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 11,616 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.6. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,417 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.